Sanofi India vs Peers
- Market cap
- ₹6,771 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹2,116.73 – ₹3,968.87
Sanofi India ranks 1st by market capitalisation among 1 Drug Manufacturers - General companies tracked by ATS. Its largest peers are Sanofi India. Its P/E of 22.5 compares with a peer median of 22.5.
Sanofi India vs Drug Manufacturers - General peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Sanofi India | 2,939.90 | -1.34% | 6,771 | 22.5 | 2.85 | 14.5% | +18.5% |
| Sanofi India | 2,939.90 | -1.34% | 6,771 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Sanofi India peer comparison — frequently asked questions
Who are Sanofi India's competitors?
Sanofi India's listed peers in Drug Manufacturers - General include Sanofi India, ranked here by market capitalisation.
How does Sanofi India's P/E compare with its peers?
Sanofi India trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - General peers shown.
Which is the largest company among Sanofi India's peers?
By market capitalisation, the largest company in the group is Sanofi India at ₹6,771 crore, against ₹6,771 crore for Sanofi India.
Same Data For Peers
Trade Sanofi India With ATS
Track SANOFI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.